AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient
- First Posted Date
- 2010-10-01
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 40
- Registration Number
- NCT01213160
- Locations
- 🇯🇵
Research Site, Sapporo-shi, Japan
Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients
- First Posted Date
- 2010-10-01
- Last Posted Date
- 2014-09-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 251
- Registration Number
- NCT01213173
- Locations
- 🇨🇳
Research Site, Tianjing, China
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice
Completed
- Conditions
- S. Aureus Bloodstream Infection
- First Posted Date
- 2010-09-30
- Last Posted Date
- 2012-11-27
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 203
- Registration Number
- NCT01212601
- Locations
- 🇨🇳
Research Site, Kunming, Yunnan, China
A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2010-09-30
- Last Posted Date
- 2011-03-08
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 186
- Registration Number
- NCT01212575
- Locations
- 🇩🇰
Research Site, Tonder, Denmark
Zomig - Treatment of Acute Migraine Headache in Adolescents
- First Posted Date
- 2010-09-29
- Last Posted Date
- 2016-05-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1653
- Registration Number
- NCT01211145
- Locations
- 🇸🇰
Research Site, Zvolen, Slovakia
Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France
Completed
- Conditions
- Healthy
- First Posted Date
- 2010-09-29
- Last Posted Date
- 2013-01-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 8186
- Registration Number
- NCT01211652
- Locations
- 🇫🇷
Research Site, Yzeure, France
An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2011-10-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 58
- Registration Number
- NCT01210339
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Epanova® Compared to Lovaza® In a Pharmacokinetic, Single-dose, Evaluation
Phase 2
Completed
- Conditions
- Severe Hypertriglyceridemia
- Interventions
- Drug: Epanova (4 g) and Lovaza (4 g)
- First Posted Date
- 2010-09-24
- Last Posted Date
- 2015-07-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 54
- Registration Number
- NCT01208961
- Locations
- 🇺🇸
Radiant Research, Chicago, Illinois, United States
Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Completed
- Conditions
- Hormon Receptor Positive Breast Cancer
- First Posted Date
- 2010-09-24
- Last Posted Date
- 2013-07-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 90
- Registration Number
- NCT01208779
- Locations
- 🇷🇸
Research Site, Belgrade, Serbia
Study in Healthy Males to Assess Bioavailability of 4 Different Fostamatinib Tablets
- First Posted Date
- 2010-09-23
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT01208155
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States